Finansial

Diskusi Teknikal Musiman

Net income before discontinued operations dari ZyVersa Therapeutics, Inc..

Data tahunan

2021

2022

2023

TTM

‪‪−100,00 M‬‬

‪‪−75,00 M‬‬

‪‪−50,00 M‬‬

‪‪−25,00 M‬‬

‪0,00‬

Periode

Nilai

Perubahan

% Perubahan

TTM

‪‪−21,33 M‬‬

+‪‪76,97 M‬‬

+‪78,30‬%

2023

‪‪−98,30 M‬‬

‪‪−84,18 M‬‬

‪−596,03‬%

2022

‪‪−14,12 M‬‬

‪‪−6,04 M‬‬

‪−74,69‬%

2021

‪‪−8,08 M‬‬

+‪‪4,60 M‬‬

+‪36,26‬%

Data per kuartal

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−80,00 M‬‬

‪‪−60,00 M‬‬

‪‪−40,00 M‬‬

‪‪−20,00 M‬‬

‪0,00‬

Periode

Nilai

Perubahan

% Perubahan

Q3 '24

‪‪−2,40 M‬‬

+‪‪362,49 K‬‬

+‪13,12‬%

Q2 '24

‪‪−2,76 M‬‬

+‪‪62,99 K‬‬

+‪2,23‬%

Q1 '24

‪‪−2,83 M‬‬

+‪‪10,51 M‬‬

+‪78,81‬%

Q4 '23

‪‪−13,34 M‬‬

‪‪−10,44 M‬‬

‪−359,57‬%

Q3 '23

‪‪−2,90 M‬‬

+‪‪75,61 M‬‬

+‪96,30‬%

Q2 '23

‪‪−78,51 M‬‬

‪‪−74,97 M‬‬

‪‪−2,12 K‬‬%

Q1 '23

‪‪−3,54 M‬‬

+‪‪1,13 M‬‬

+‪24,23‬%

Q4 '22

‪‪−4,68 M‬‬

‪‪−984,68 K‬‬

‪−26,67‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21